D-erythro-dihydrosphingosine suppresses melanoma growth and induces caspase-dependent GSDME-mediated pyroptosis

Background Melanoma is an aggressive skin malignancy characterized by high metastatic potential and therapeutic resistance, highlighting the need for candidate agents with distinct mechanisms of tumor-cell killing. D-erythro-dihydrosphingosine (DES), a naturally occurring sphingoid base, has not been well characterized in melanoma. Methods In this study, we investigated the anti-melanoma activity of DES and its underlying cell-death mechanism. Results DES reduced A375 cell viability in a concentration-dependent manner, with an IC 50 of approximately 0.5701 μM, and induced progressive membrane-disruptive morphological changes and LDH release. Similar morphological alterations and GSDME cleavage were observed in SK-MEL-28 cells. The pan-caspase inhibitor Z-VAD-FMK markedly attenuated DES-induced membrane damage and GSDME cleavage. DES also promoted PARP cleavage and activation of caspase-3 and caspase-9 together with accumulation of the pore-forming GSDME-N fragment. Importantly, depletion of GSDME using two independent knockdown constructs substantially reduced DES-induced LDH release and restored cell viability, providing functional evidence that GSDME contributes to DES-induced melanoma-cell death. In a melanoma xenograft model, DES significantly suppressed tumor growth and was accompanied by increased GSDME-N, cleaved caspase-3, cleaved caspase-9, and cleaved PARP in tumor tissues. No marked changes in body weight, serum ALT, AST, CK-MB, or BUN levels, or major-organ histopathology were observed at the tested doses. Exploratory network pharmacology, molecular docking, and molecular dynamics simulations further nominated EGFR as a candidate DES-associated protein. Conclusions Collectively, these findings demonstrate that DES exerts anti-melanoma activity and induces caspase-associated, GSDME-dependent pyroptotic cell death, supporting its further investigation as a candidate anti-melanoma agent.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-19
DOI
https://doi.org/10.3389/fonc.2026.1973849
Primary Topic
Cell death mechanisms and regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

D-erythro-dihydrosphingosine suppresses melanoma growth and induces caspase-dependent GSDME-mediated pyroptosis

Zhiwen Yan, Xueqin Chen, Fang-ping Zheng, Yuan Cheng et al.
Frontiers in Oncology
Cell death mechanisms and regulation
article

D-erythro-dihydrosphingosine suppresses melanoma growth and induces caspase-dependent GSDME-mediated pyroptosis

Zhiwen Yan, Xueqin Chen, Fang-ping Zheng, Yuan Cheng, Yu-Xuan Huang, Zhi-Qiang Que
article en

Abstract

Background Melanoma is an aggressive skin malignancy characterized by high metastatic potential and therapeutic resistance, highlighting the need for candidate agents with distinct mechanisms of tumor-cell killing. D-erythro-dihydrosphingosine (DES), a naturally occurring sphingoid base, has not been well characterized in melanoma. Methods In this study, we investigated the anti-melanoma activity of DES and its underlying cell-death mechanism. Results DES reduced A375 cell viability in a concentration-dependent manner, with an IC 50 of approximately 0.5701 μM, and induced progressive membrane-disruptive morphological changes and LDH release. Similar morphological alterations and GSDME cleavage were observed in SK-MEL-28 cells. The pan-caspase inhibitor Z-VAD-FMK markedly attenuated DES-induced membrane damage and GSDME cleavage. DES also promoted PARP cleavage and activation of caspase-3 and caspase-9 together with accumulation of the pore-forming GSDME-N fragment. Importantly, depletion of GSDME using two independent knockdown constructs substantially reduced DES-induced LDH release and restored cell viability, providing functional evidence that GSDME contributes to DES-induced melanoma-cell death. In a melanoma xenograft model, DES significantly suppressed tumor growth and was accompanied by increased GSDME-N, cleaved caspase-3, cleaved caspase-9, and cleaved PARP in tumor tissues. No marked changes in body weight, serum ALT, AST, CK-MB, or BUN levels, or major-organ histopathology were observed at the tested doses. Exploratory network pharmacology, molecular docking, and molecular dynamics simulations further nominated EGFR as a candidate DES-associated protein. Conclusions Collectively, these findings demonstrate that DES exerts anti-melanoma activity and induces caspase-associated, GSDME-dependent pyroptotic cell death, supporting its further investigation as a candidate anti-melanoma agent.

Frontiers in OncologyVol. 16
Fujian Medical University (CN), Xiamen University (CN), First Affiliated Hospital of Xiamen University (CN)
Cell death mechanisms and regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon